Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.

Literature DB >> 7570443

Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.

J W Upham¹, M J Garlepp, A W Musk, B W Robinson.

Abstract

Entities: Disease

Mesh：

Substances：
Interleukin-6
Interferons

Year: 1995 PMID： 7570443 PMCID： PMC474913 DOI： 10.1136/thx.50.8.887

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

56 in total

1. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.

Authors: V W Rusch; S Piantadosi; E C Holmes
Journal: J Thorac Cardiovasc Surg Date: 1991-07 Impact factor: 5.209

2. Differential immunohistochemical staining for retinoblastoma protein with the antibodies C15 and 1F8 in malignant mesothelioma.

Authors: M Ramael; K Segers; E Van Marck
Journal: Pathol Res Pract Date: 1994-02 Impact factor: 3.250

3. Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An Italian Lung Cancer Task Force (FONICAP) Phase II study.

Authors: A Ardizzoni; R Rosso; F Salvati; V Fusco; A Cinquegrana; M De Palma; J Serrano; M C Pennucci; E Soresi; M Crippa
Journal: Cancer Date: 1991-06-15 Impact factor: 6.860

4. Simian virus 40-like DNA sequences in human pleural mesothelioma.

Authors: M Carbone; H I Pass; P Rizzo; M Marinetti; M Di Muzio; D J Mew; A S Levine; A Procopio
Journal: Oncogene Date: 1994-06 Impact factor: 9.867

5. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study.

Authors: H Takita; T S Mang; G M Loewen; J G Antkowiak; D Raghavan; J R Grajek; T J Dougherty
Journal: Ann Thorac Surg Date: 1994-10 Impact factor: 4.330

6. Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestos-induced rat mesothelioma.

Authors: C Walker; E Bermudez; W Stewart; J Bonner; C J Molloy; J Everitt
Journal: Cancer Res Date: 1992-01-15 Impact factor: 12.701

7. Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma.

Authors: D R Fitzpatrick; H Bielefeldt-Ohmann; R P Himbeck; A G Jarnicki; A L Marzo; B W Robinson
Journal: Growth Factors Date: 1994 Impact factor: 2.511

8. In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines.

Authors: L Zeng; A Buard; I Monnet; C Boutin; J Fleury; L Saint-Etienne; P Brochard; J Bignon; M C Jaurand
Journal: Int J Cancer Date: 1993-09-30 Impact factor: 7.396

9. A new device for the treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report.

Authors: P Y Carry; A Brachet; F N Gilly; A C Sayag; P Y Petit; C Rochette; P Mulsant; B Guibert; G Braillon; V Banssillon
Journal: Oncology Date: 1993 Sep-Oct Impact factor: 2.935

10. Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model.

Authors: H Bielefeldt-Ohmann; D R Fitzpatrick; A L Marzo; A G Jarnicki; R P Himbeck; M R Davis; L S Manning; B W Robinson
Journal: Cancer Immunol Immunother Date: 1994-12 Impact factor: 6.968

3 in total